Abstract
Alterations in the degree of the phosphorylation of ERK1/2, Akt-1 and p70 S6K in mouse skeletal and cardiac muscle was examined in vivo following an intraperitoneal injection of des IGF-I. Plasma levels of insulin, IGF-I and glucose were measured. The administration of des IGF-I had no effect on plasma levels of insulin, or IGF-I, but plasma glucose levels were decreased about 50% (p < 0.01). In both skeletal and cardiac muscle, des IGF-I increased the phosphorylation of Akt-1 at Ser 473 (p < 0.01) with no change in the phosphorylation of p44 and p42 MAP kinases at Thr202/Tyr204. The phosphorylation of p70 S6K at Thr421/Ser424 was increased in skeletal muscle (p < 0.01), but not in cardiac muscle. The phosphorylation of the nuclear transcription factor CREB phosphorylation at Ser 133 was not significantly changed in either skeletal or cardiac muscle. Des IGF-I increased the phosphorylation of the transcription factor FKHR in cardiac muscle only (p < 0.05). These data demonstrate that the administration of des IGF-I had differential effects on the activation of the MAP kinase and PI 3-kinase pathways in mouse skeletal and cardiac muscle.
Similar content being viewed by others
References
Petley T, Graff K, Jiang W, Yang H, Florini J: Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 31: 70–76, 1999
Willis PE, Chadan S, Baracos V, Parkhouse WS: Acute exercise attenuates age-associated resistance to insulin-like growth factor I. Am J Physiol 272: E397–E404, 1997
Dardevet D, Sornet C, Vary T, Grizard J: Phosphatidylinositol 3–kinase and p70 S6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Endocrinology 137: 4087–4094, 1996
LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev 16: 143–163, 1995
Eyster KM: Introduction to signal transduction, a primer for untangling the web of intracellular messengers. Biochem Pharmacol 55: 1927–1938, 1998
Fuller SJ, Mynett JR, Sugden PH: Stimulation of cardiac protein synthesis by insulin-like growth factors. Biochem J 282: 85–90, 1992
Freestone NS, Ribaric S, Mason WT: The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol Cell Biochem 163/164: 223–229, 1996
Lavandero S, Foncea R, Perez V, Sapag-Hagar M: Effect of inhibitors of signal transduction on IGF-1–induced protein synthesis associated with hypertrophy in cultured neonatal rat ventricular myocytes. FEBS Lett 422: 193–196, 1998
Laser M, Kasi VS, Hamawaki M, Cooper G IV, Kerr CM, Kuppuswamy D: Differential activation of p70 and p85 S6 Kinase isoforms during cardiac hypertrophy in the adult mammal. J Biol Chem 273: 25610–24619, 1998
Foncea R, Andersson M, Ketterman A, Blakesley V, Sapag-Hagar M, Sugend PH, LeRoith D, Lavandero S: Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J Biol Chem 272: 19115–19124, 1997
Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR: The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272: 6653–6662, 1997
Murphy LJ: Insulin-like growth factor-binding proteins: Functional diversity or redundancy? J Mol Endocrinol 21: 97–107, 1998
Thissen JP, Ketalslegers JM, Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocrine Rev 15: 80–101, 1994
Tomas FM, Walton PE, Dunshea F, Ballard FJ: IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. J Endocrinol 155: 377–386, 1997
Tomas FM, Lemmey AB, Read LC, Ballard FJ: Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection. J Endocrinol 150: 77–84, 1996
Yamamoto H, Murphy LJ: Enzymatic conversion of IGF-I to des(1-3)IGF-I in rat serum and tissues: A further potential site of growth hormone regulation of IGF-I action. J Endocrinol 146: 141–148, 1995
Ballard FJ, Wallace JC, Francis GL, Read LC, Tomas FM: Des(1-3)IGF-I: A truncated from of insulin-like growth factor-I. Int J Biochem Cell Biol 28: 1085–1087, 1996
Goodyear LJ, Chang PY, Sherwood DJ, Dufresne SD, Moller DE: Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J Physiol 271: E403–E408, 1996
Fearson G, Robinson F, Gibson TB, Xu B, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocrine Rev 22: 153–183, 2001
Weng Q, Kozlowski M, Belham C, Zhang A, Comb MJ, Avruch J: Regulation of the p70 S6 kinase by phosphorylation in vivo. J Biol Chem 273: 16621–16629, 1998
Eguchi S, Iwasaki H, Ueno K, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, Inagami T: Intracellular signalling of angiotensin IIinduced p70 S6 kinase phosphorylation at Ser 411 in vascular smooth muscle cells. J Biol Chem 274: 36843–36851, 1999
Meier R, Alessi DR, Cron P, Andjelkoviæ M, Hemmings BA: Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase B. J Biol Chem 272: 30491–30497, 1997
Petley T, Graff K, Jiang W, Yang H, Florini J: Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 31: 70–76, 1999
Meyts PD, Wallach B, Christoffersen CT, Ursø B, Grønskov K, Latus LJ, Yakushiji F, Ilondo MM, Shymko RM: The insulin-like growth factor-I receptor. Horm Res 42: 152–169, 1994
Nissley P, Lopaczynski W: Insulin-like growth factor receptors. Growth Factors 5: 29–43, 1991
Adi S, Wu NY, Rosenthal SM: Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin. Endocrinology 142: 498–501, 2001
Wojtaszewski JFP, Higaki Y, Hirshman MF, Michael MD, Dufresne SD, Kahn CR, Goodyear LJ: Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J Clin Invest 104: 1257–1264, 1999
Sherwood DJ, Dufresne SD, Markuns JF, Cheatham B, Moller DE, Aronson D, Goodyear LJ: Differential regulation of MAP kinase, p70 S6K, and Akt by contraction and insulin in rat skeletal muscle. Am J Physiol 276: E870–E878, 1999
Holst LS, Mulder H, Manganiello V, Sundler F, Ahren B, Holm C, Degerman E: Protein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I. Biochem Biophys Res Commun 250: 181–186, 1998
Kohn AD, Summers SA, Birnbaum MJ, Roth RA: Expression of a constitutively active Akt Ser/Thr kinase in 3T3–L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372–31378, 1996
Kimball SR, Horetsky RL, Jefferson LS: Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts. J Physiol 274: C221–228, 1998
Liu Y, Gorospe M, Kokkonen GC, Boluyt MO, Younes A, Mock YM, Wang X, Roth GS, Holbrook NJ: Impairments in both p70 S6 Kinase and extracellular signal-regulated kinase signaling pathways contribute to the decline in proliferative capacity of aged hepatocytes. Exp Cell Res 240: 40–48, 1998
Sale EM, Atkinson PPG, Arnott CH, Chad JE, Sale GJ: Role of ERK1/2 and p70 S6K pathway in insulin signaling of protein synthesis. FEBS Lett 446: 122–126, 1999
Hemmings BA: Akt-signaling - linking membrane events to life and death decisions. Science 275: 628–630, 2001
Chan TO, Rittenhouse SE, Tsichlis PN: AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositidedependent phosphorylation. Ann Rev Biochem 68: 965–1014, 1999
Whalin M, Guroff G: The use of rapamycin and wortmannin in the dissection of the signal transduction pathways regulating the phosphorylation of the ribosomal protein S6. In: Y. Gutman, P. Lazarovici (eds), Cellular and Molecular Mechanisms of Toxin Action, Vol. 1: Toxins and Signal Transduction. Hardwood Academic, Amsterdam, 1997, pp 427–455
Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, Sacchi A, Romano G, Reiss K, Baserga R: Insulin receptor substrate-1, p70 S6K, and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem 275: 25451–25459, 2000
Haddad TC, Conover CA: Insulin and interleukin-4 desensitization to the mitogenic effects of insulin-like growth factor-I - pivotal role for insulin receptor substrate-2. J Biol Chem 272: 19525–19531, 1997
Zimmermann S, Moelling K: Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286: 1741–1742, 1999
Nakea J, Park B, Accili D: Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on Serine 253 through a Wortmannin-sensitive pathway. J Biol Chem 274: 15982–15985, 1999
Pugazhenthi S, Boras T, O'Connor D, Meintzer MK: Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. J Biol Chem 274: 2829–2837, 1999
Biggs WH III, Meisenhelder J, Hunter T, Cavenee WK, Arden KC: Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96: 7421–7426, 1999
Rena G, Guo S, Cichy SC, Unterman TG, Cohen P: Phosphorylation of the transcription factor forkhead family member FKHR by protein Kinase B. J Biol Chem 274: 17179–17183, 1999
Rena G, Prescott AR, Guo S, Cohen P, Unterman TG: Roles of the forkhead in rhadomyosarcoma (FKHR) phosphorylation sites in regulating 14–3–3 binding, transactivation and nuclear targeting. Biochem J 354: 605–612, 2001
Du K, Montminy M: CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273: 32377–32379, 1998
Zheng W, Kar S, Quirion R: Insulin-like growth factor-1–induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem 275: 39152–39158, 2000
Liu X, Gupta AK, Corry PM, Lee YJ: Hypoglycemia-induced c-Jun phosphorylation is mediated by c-Jun N-terminal kinase 1 and Lyn kinase in drug-resistant human breast carcinoma MCF-7/ADR cells. J Biol Chem 272: 11690–11693, 1997
Gupta AK, Lee YJ, Galoforo SS, Berns CM, Martinez AA, Corry PM, Wu X, Guan KL: Differential effect of glucose deprivation on MAPK activation in sensitive human breast carcinoma MCF-7 and multidrug resistant MCF-7/ADR cells. Mol Cell Biochem 170: 23–30, 1997
Evans ML, Pernet A, Lomas J, Jones J, Amiel SA: Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care 23: 893–897, 2000
Turinsky J, Damrau-Abney A: Akt kinases and 2–deoxyglucose uptake in rat skeletal muscles in vivo: Study with insulin and exercise. Am J Physiol 276: R277–R282, 1999
Carlson CJ, Fan Z, Gordon SE, Booth FW: Time course of the MAPK and PI3–kinase response within 24 h of skeletal muscle overload. J Appl Physiol 91: 2079–2087, 2001
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, M., Li, C. & Parkhouse, W. Differential effects of des IGF-1 on ERKs, AKT-1 and P70 S6K activation in mouse skeletal and cardiac muscle. Mol Cell Biochem 236, 115–122 (2002). https://doi.org/10.1023/A:1016164601887
Issue Date:
DOI: https://doi.org/10.1023/A:1016164601887